Cargando…

p16, HPV, and Cetuximab: What Is the Evidence?

Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide. It has recently been appreciated that human papillomavirus (HPV) status (or p16 status, which is a frequently used surrogate for HPV status) is prognostic for oropharyngeal SCCHN. Here, we review and cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonner, James A., Mesia, Ricard, Giralt, Jordi, Psyrri, Amanda, Keilholz, Ulrich, Rosenthal, David I., Beier, Frank, Schulten, Jeltje, Vermorken, Jan B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2017
Materias:	Head and Neck Cancers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507644/ https://www.ncbi.nlm.nih.gov/pubmed/28526718 http://dx.doi.org/10.1634/theoncologist.2016-0433

Ejemplares similares

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas
por: Dahm, Valerie, et al.
Publicado: (2018)

Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma
por: Weiss, Bernhard G., et al.
Publicado: (2020)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

Meta‐Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
por: Mané, Maïmouna, et al.
Publicado: (2020)

The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
por: Huiskamp, L. F. J., et al.
Publicado: (2020)

Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer
por: Snietura, Miroslaw, et al.
Publicado: (2010)

Stem cell markers in oral and oropharyngeal squamous cell carcinomas in relation to the site of origin and HPV infection: clinical implications
por: Rizzo, Davide, et al.
Publicado: (2020)

Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma
por: Bar, Julia K., et al.
Publicado: (2021)

The prognostic-nutritional index in HPV-negative head and neck squamous cell carcinoma treated with upfront surgery: a multi-institutional series
por: Tomasoni, Michele, et al.
Publicado: (2023)

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial
por: Vermorken, J. B., et al.
Publicado: (2014)

The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications
por: Hussain, Timon, et al.
Publicado: (2022)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

Laryngectomy: what is the impact of the type of surgery on life quality and sexual function?
por: Akil, F., et al.
Publicado: (2017)

Mucosal Melanoma of the Oral Cavity: What is the Role of Elective Neck Dissection?
por: Haimowitz, Sean, et al.
Publicado: (2022)

Upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) in HPV-positive oropharyngeal cancer: real-world data from a tertiary comprehensive cancer centre
por: Zorzi, Stefano Filippo, et al.
Publicado: (2022)

Free flap head and neck reconstruction in the elderly: what is the impact on quality of life?
por: FERRI, A., et al.
Publicado: (2019)

Donor site morbidity of the fasciocutaneous radial forearm flap: what does the patient really bother?
por: de Witt, Christien A., et al.
Publicado: (2007)

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
por: Bonner, James A., et al.
Publicado: (2016)

The impact of 2 weeks wait referral on survival of head and neck cancer patients
por: Rovira, Aleix, et al.
Publicado: (2023)

Evaluation of classification and regression tree (CART) model in weight loss prediction following head and neck cancer radiation therapy
por: Cheng, Zhi, et al.
Publicado: (2017)

Tracheostomy, ventilatory wean, and decannulation in COVID-19 patients
por: Tornari, Chrysostomos, et al.
Publicado: (2020)

Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect?
por: De Luca, Pietro, et al.
Publicado: (2021)

Do salivary bypass tubes lower the incidence of pharyngocutaneous fistula following total laryngectomy? A retrospective analysis of predictive factors using multivariate analysis
por: Hone, Robert W. A., et al.
Publicado: (2016)

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers
por: Noronha, Vanita, et al.
Publicado: (2017)

Endoscopic Fluorescence‐Guided Surgery for Sinonasal Cancer Using an Antibody‐Dye Conjugate
por: Hart, Zachary P., et al.
Publicado: (2019)

Recurrent pigmented villonodular synovitis of the temporomandibular joint
por: Allen, Amanda, et al.
Publicado: (2018)

Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation
por: Lazarev, Stanislav, et al.
Publicado: (2017)

Quantitative clinical outcomes of therapy for head and neck lymphedema
por: Doke, Kaleigh N., et al.
Publicado: (2018)

Hazards of sparing the ipsilateral parotid gland in the node-positive neck with intensity modulated radiation therapy: Spatial analysis of regional recurrence risk
por: Chen, Allen M., et al.
Publicado: (2017)

The Efficacy of a Custom-Made Mouthpiece With Spacer to Reduce Osteoradionecrosis in Carbon-Ion Radiation Therapy for Tongue-Base Tumor
por: Ikawa, Hiroaki, et al.
Publicado: (2018)

Association between variant alleles of major histocompatibility complex class II regulatory genes and nasopharyngeal carcinoma susceptibility
por: Zhou, Ping, et al.
Publicado: (2020)

Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma
por: Thierauf, Julia, et al.
Publicado: (2019)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
por: Kamal, Mona, et al.
Publicado: (2019)

Long-Term Aspects of Quality of Life in Head and Neck Cancer Patients Treated With Intensity Modulated Radiation Therapy: A 5-Year Longitudinal Follow-up and Comparison with a Normal Population Cohort
por: Abel, Edvard, et al.
Publicado: (2019)

Spatial Radiation Dose Influence on Xerostomia Recovery and Its Comparison to Acute Incidence in Patients With Head and Neck Cancer
por: Guo, Yue, et al.
Publicado: (2019)

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors
por: Yu, Nathan Y., et al.
Publicado: (2019)

Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?
por: Corkum, Mark T., et al.
Publicado: (2019)

Emotional Quality of Life After Radiation Therapy for Oropharyngeal Carcinoma
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2019)

Treating head and neck tumors during the SARS‐CoV‐2 epidemic, 2019 to 2020: Sichuan Cancer Hospital
por: Cai, Yong‐Cong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04vd8g827qbnlnsq3gp2ho0l50